EUVIMEDEUVIMED entdecken
Crossref

Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML

J.Y.C. Wong, M. Al Malki, D. Yang, V. Adhikarla, F. Sahebi, A. Salhotra, D.M. Yamauchi, S.V. Dandapani, J. Song, C. Han, A. Liu, P. Yazaki und 8 weitere

International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e2

DOI: 10.1016/j.ijrobp.2026.02.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von J.Y.C. Wong und 19 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wong, J., Malki, M. A., Yang, D., Adhikarla, V., Sahebi, F., Salhotra, A., Yamauchi, D., Dandapani, S., Song, J., Han, C., Liu, A., Yazaki, P., Shively, J., Wu, A., Hui, S., Smith, E., Marcucci, G., Forman, S., Nakamura, R., & Stein, A. (2026). Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML. International Journal of Radiation Oncology*Biology*Physics, 125(1), e2. https://doi.org/10.1016/j.ijrobp.2026.02.004

Vancouver

Wong J, Malki MA, Yang D, Adhikarla V, Sahebi F, Salhotra A, et al. Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e2. doi:10.1016/j.ijrobp.2026.02.004

BibTeX
@article{Wong2026,
  author = {Wong, J.Y.C. and Malki, M. Al and Yang, D. and Adhikarla, V. and Sahebi, F. and Salhotra, A. and Yamauchi, D.M. and Dandapani, S.V. and Song, J. and Han, C. and Liu, A. and Yazaki, P. and Shively, J.E. and Wu, A. and Hui, S.K. and Smith, E. and Marcucci, G. and Forman, S.J. and Nakamura, R. and Stein, A.},
  title = {Phase I Trial Combining Radiopharmaceutical Therapy (RPT) with Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed or Refractory (R/R) AML},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {125},
  number = {1},
  pages = {e2},
  doi = {10.1016/j.ijrobp.2026.02.004}
}
Kostenlos starten →